Search Within

Shanu Modi

  1. "2023"
Formats
  1. Meeting Abstract (10)
  2. Journal Article (3)
  3. Review (2)
Groups
  1. Breast Medicine Service (15)
  2. Department of Medicine (15)
  3. Solid Tumor Oncology Division (15)
  4. GSK Faculty (5)
  5. Biostatistics Service (4)
  6. Department of Pathology and Laboratory Medicine (4)

More Groups

People
  1. Andrew Seidman (3)
  2. Chau Dang (3)
  3. Mark Robson (3)
  4. Andrea Barrio (2)
  5. Edi Brogi (2)
  6. Emanuela Ferraro (2)

More People

Years
  1. 2023 (15)
Publications
  1. Annals of Oncology (6)
  2. Journal of Clinical Oncology (4)
  3. Breast (1)
  4. European Heart Journal (1)
  5. Nature Communications (1)
  6. Therapeutic Advances in Medical Oncology (1)

More Publications

Publishers
  1. Oxford University Press (7)
  2. American Society of Clinical Oncology (4)
  3. Nature Publishing Group (2)
  4. Elsevier Inc. (1)
  5. Sage Publications Ltd. (1)

Results (15)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • An age-specific pooled analysis of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-positive (HER2+) metastatic breast cancer (mBC) from DESTINY-Breast01, -02, and -03
    Meeting Abstract

    Krop, I. E.; Wildiers, H.; Hurvitz, S. A.; Cortes, J.; Im, S. A.; Iwata, H.; Andre, F.; Saura, C.; Modi, S.; Kim, S. B.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Invasive disease free survival and brain metastasis rates in patients treated with neoadjuvant chemotherapy with trastuzumab and pertuzumab
    Meeting Abstract

    Chew, S.; Ferraro, E.; Chen, Y.; Barrio, A. V.; Kelly, D. W.; Modi, S.; Seidman, A. D.; Wen, H. Y.; Brogi, E.; Robson, M. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Systems-level analyses of protein-protein interaction network dysfunctions via epichaperomics identify cancer-specific mechanisms of stress adaptation
    Journal Article

    Rodina, A.; Xu, C.; Digwal, C. S.; Joshi, S.; Patel, Y.; Santhaseela, A. R.; Bay, S.; Merugu, S.; Alam, A.; Yan, P.; more...
    Nature Communications (2023)

    Fulltext@MSK | Save
  • ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer
    Review

    Tarantino, P.; Viale, G.; Press, M. F.; Hu, X.; Penault-Llorca, F.; Bardia, A.; Batistatou, A.; Burstein, H. J.; Carey, L. A.; Cortes, J.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Targeting HER2-low in metastatic breast cancer: An evolving treatment paradigm
    Review

    Yang, C.; Brezden-Masley, C.; Joy, A. A.; Sehdev, S.; Modi, S.; Simmons, C.; Henning, J. W.
    Therapeutic Advances in Medical Oncology (2023)

    Fulltext@MSK | Save